Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PILOT STUDY TO EVALUATE THE PROGRESSION OF THE DISEASE AND RESPONSE TO SUPPLEMENTATION WITH POSTBIOTICS IGEN-0222 IN PATIENTS WITH MACULAR DEGENERATION

NCT05056025 is registered in ClinicalTrials.gov with Institut de la Macula y la Retina as lead sponsor.

NCT NCT05056025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05056025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PILOT STUDY TO EVALUATE THE PROGRESSION OF THE DISEASE AND RESPONSE TO SUPPLEMENTATION WITH POSTBIOTICS IGEN-0222 IN PATIENTS WITH MACULAR DEGENERATION
Lead sponsor
Institut de la Macula y la Retina
Phase
Not applicable
Overall status
Unknown status
Start date
December 2, 2020
Completion date
January 31, 2024
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amd, drusen (degenerative) of macula, bilateral, drusen stage macular degeneration, reticular pseudodrusen, soft drusen